Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers
- 29 April 2004
- journal article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 49 (6) , 312-318
- https://doi.org/10.1007/s10038-004-0146-3
Abstract
Journal of Human Genetics, official journal of the Japan Society of Human Genetics, publishes original articles and reviews on all aspects of human genetics, including medical genetics and genomicsKeywords
This publication has 41 references indexed in Scilit:
- Immunohistochemical expression of cyclin D1, E2F‐1, and Ki‐67 in benign and malignant thyroid lesionsThe Journal of Pathology, 2002
- E2F1 selects tumour cells for both life and deathThe Journal of Pathology, 2002
- Mutant Mouse Models Reveal the Relative Roles of E2F1 and E2F3 In VivoMolecular and Cellular Biology, 2002
- The RET/PTC Oncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic LesionsJournal of Clinical Endocrinology & Metabolism, 2002
- E2F4 and E2F5 Play an Essential Role in Pocket Protein–Mediated G1 ControlMolecular Cell, 2000
- Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid CarcinomasThe American Journal of Pathology, 2000
- Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell lineGenomics, 1995
- Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid glandThe Journal of Pathology, 1994
- The retinoblastoma protein is phosphorylated during specific phases of the cell cycleCell, 1989
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989